SFC Fluidics key facts
as of Oct 2026- Developer of a dual-hormone patch pump designed to advance healthcare and improve quality of life through microfluidic technologies.
- SFC Fluidics is valued at approximately $31.0M as of Oct 2026 (last reported valuation).
- It has raised $7.7M across 3 recorded rounds; the latest was Seed Round ($250K) in Oct 2025.
- Notable investors include US National Science Foundation, United States Department of War, Keiretsu Forum, National Aeronautics and Space Administration, Breakthrough T1D — 13 tracked in total.
- SFC Fluidics has filed 6 Form Ds with the SEC since 2011, most recently Jun 2023 ($55K sold to 2 investors).
- Status: Privately Held (backing).
SFC Fluidics's last reported valuation, Aug 2022. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch SFC Fluidics: the Monday email on marks, rounds and moves
SFC Fluidics funding rounds
3 roundsWho backs SFC Fluidics
13+Membership and data by Private Market View
SFC Fluidics valuation
SFC Fluidics's last reported valuation was $31 million in Aug 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has SFC Fluidics raised?
SFC Fluidics has raised $7.7 million in total; 3 of its rounds are on record, from 2013 on. The largest on record was a $500,000 seed round in Dec 2015; the most recent was a $250,000 seed round in Oct 2025.
SFC Fluidics has filed 6 Form Ds with the SEC since 2011, most recently in Jun 2023 ($55,000 sold to 2 investors).
SFC Fluidics investors
13 investors are on record for SFC Fluidics, including US National Science Foundation, United States Department of War, Keiretsu Forum and National Aeronautics and Space Administration. The seed round in Oct 2025 drew 3 investors.
About SFC Fluidics
Developer of a dual-hormone patch pump designed to advance healthcare and improve quality of life through microfluidic technologies. The company's pump can control the delivery of both insulin and glucagon in a discreet patch pump that is the same size as the insulin-only patch pumps, and the technology is also suitable for the delivery of other subcutaneous biologics, enabling diabetic patients to improve their lifestyle and avoid complications.
- Sector
- Healthcare
- HQ
- Fayetteville, AR, United States
- Founded
- 2003
- Employees
- 10
- Website
- sfc-fluidics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.